#United States #Washington, D.C. #Health Policy #mRNA vaccines #Independent Medical Alliance

Major Policy Shift in Vaccine Recommendations

Today, the Independent Medical Alliance (IMA) celebrated a significant policy victory as the U.S. Department of Health and Human Services (HHS) announced the exclusion of mRNA COVID-19 vaccines from the recommended immunization schedules for children and pregnant women. This decision stems from the IMA's impactful "Smart Moms Ask" campaign, which engaged tens of thousands of concerned citizens over the past ten days. The campaign also featured plans for a march on the HHS headquarters in Washington, D.C.

The recent HHS decision marks a pivotal moment in public health policy, aligning with the IMA's innovative "Four Pillars of Healthcare Reform." This framework emphasizes the importance of evidence-based medical practices and policies that prioritize patient safety. As Dr. Kat Lindley, Director of the IMA Fellowship Program stated, "There was no medical justification for maintaining the mRNA vaccines on the schedules for children and pregnant women. We commend Secretary Kennedy and the entire HHS team for their prompt action in this matter."

Concerns regarding the safety of mRNA vaccines have been on the rise, with evidence emerging about potential risks outweighing any perceived benefits. A study published in the International Journal of Cardiovascular Research Innovation highlighted alarming findings: a 620% increase in the risk of myocarditis and a 175% increase in the risk of pericarditis among young men post-vaccination. Such findings have intensified scrutiny, particularly regarding the implications for younger demographics. As early as November 2021, the IMA and other medical professionals voiced concerns regarding the unusually high risks posed by mRNA technology in healthy children.

Dr. Joseph Varon, IMA President and Chief Medical Officer, remarked, "The HHS's decision acknowledges the increasing body of scientific evidence regarding the risks associated with mRNA vaccines, particularly for vulnerable groups such as children and pregnant women. This move is crucial for enhancing patient safety and paves the way for a comprehensive reassessment of mRNA technology in vaccines."

The success of the IMA’s campaign is a reflection of the growing public sentiment favoring cautious and transparent healthcare policies. Thousands of parents and healthcare professionals have rallied around the call for evidence-based revisions in public health guidelines. The IMA aims to continue its advocacy for clear and science-driven healthcare approaches.

About Dr. Kat Lindley

Dr. Kat Lindley is a highly regarded family physician and serves as the Director of the IMA Fellowship Program. With over 15 years in clinical practice, she is a prominent advocate for patient safety and medical autonomy. Dr. Lindley holds several leadership positions in health organizations, aiming to enhance healthcare transparency.

About Dr. Joseph Varon

Dr. Joseph Varon gained national recognition during the pandemic for his relentless efforts against COVID-19 as Chief Medical Officer at Houston’s United Memorial Medical Center. His unit achieved notable survival rates, and his commitment to patient care has made him a leading voice in the medical community.

About the IMA Four Pillars of Healthcare Reform

The IMA's "Four Pillars" lay out a strategic framework for impactful healthcare reform, with the recent ban on mRNA vaccines for children and pregnant women as a crucial milestone. This action is part of a broader agenda advocating for the repeal of the emergency use authorization surrounding mRNA vaccines. To learn more about the IMA's reform initiatives, please reach out to [email protected]

Conclusion

The Independent Medical Alliance's victory in influencing HHS policy signifies a notable shift towards prioritizing patient safety and advocating for robust, science-based healthcare practices. The organization remains steadfast in its mission to restore trust and transparency within the healthcare system, supporting a future of informed consent and proactive health strategies.